Skip to content
Wearables

Dexcom Stelo Review: Price, Use, Accuracy Evidence

Dexcom Stelo from Stelo's site, FDA and studies: who it is for, price and plans, 15-day wear, independent accuracy findings, and what CGM evidence shows.

LLLongevity Intel editorialPublished (approx.)Updated 2 min read

Compiled from published studies and manufacturer specifications, checked .

We have not tested products ourselves. How we research

Quick verdict

Stelo is an over-the-counter CGM for people not on insulin: Stelo's site shows a subscription at $89 (struck from $99), 15-day sensors and Apple Watch support. An independent Sept 2026 study of over-the-counter CGMs found 12.9% average error. Nothing shows it improves health in healthy people. It does not diagnose diabetes.

Talk to your doctor first. This is general information, not medical advice. Supplements and devices can interact with medicines and health conditions. We quote study protocols for context and do not recommend doses.

Top picks

As an Amazon Associate, Longevity Intel earns from qualifying purchases. Some links are affiliate links; we may earn a commission at no extra cost to you. Commissions never change what we write. How we make money

Over-the-counter CGM

Dexcom Stelo

Dexcom · $89 a month (struck from $99, Stelo's site, 29 Sept 2026)

Price as of July 2026. Check the retailer for the current price and availability.

Pros

  • Cleared by the FDA as an over-the-counter integrated CGM (iCGM), for people not on insulin
  • Up to 15 days per sensor; Apple Watch compatible

Cons

  • Brand footnote says about 20% of sensors may not last the full 15 days
  • Not for people with problematic hypoglycemia, since it is not designed to alert to it (FDA)
  • Independent study of OTC CGMs found 12.9% average error against fingerstick readings
View product

The short answer: Stelo is Dexcom’s over-the-counter continuous glucose monitor for people not on insulin. Stelo’s site (29 Sept 2026) shows a monthly subscription at $89 (struck from $99), sensors worn up to 15 days, Apple Watch support, and an app with coaching. The FDA cleared it for ages 2 and up not on insulin on 12 June 2026. An independent study of over-the-counter CGMs found 12.9% average error, so use it for patterns, not exact values. Nothing shows a health benefit in healthy people, and it does not diagnose diabetes. Talk to your doctor.

Facts from the brand and the FDA

  • Who it is for: people 18 and older not on insulin, per Stelo’s site; the FDA notice covers ages 2 and up not on insulin. Not for people with problematic hypoglycemia because it does not alert to it.
  • Clearance wording: an over-the-counter integrated CGM (iCGM) to detect normal and low or high glucose levels.
  • Price and plans: subscription shown at $89 (struck from $99); one-time purchase also offered; HSA/FSA eligible.
  • Wear: up to 15 days; about 20% of sensors may not last the full 15 (brand footnote).
  • App: tips and coaching, morning recaps and an AI Coach the brand says is not medical advice.

What the studies say

  • Accuracy: Sept 2026 study: 39 young adults without diabetes, OTC CGMs, MARD 12.9%, within-15%/15 mg/dL agreement 66.5%; agreement worse after sugary drinks; sensors agreed with trends but were less reliable for exact values.
  • Does it help: 2024 meta-analysis of 25 RCTs: modest benefits mostly in diabetes; no trial in healthy adults.

For the head-to-head with Abbott’s Lingo see Stelo vs Lingo; for other sensors, best continuous glucose monitors; for how to read the numbers, the CGM guide. The Stelo site has current plans.

Method note

Researched from Stelo’s site, an FDA notice and PubMed records (29 Sept 2026). We did not test the sensor. Brand pages change by region and date. General information, not medical advice.

Common questions

How accurate is the Dexcom Stelo?

We found no independent study naming Stelo alone. A September 2026 study of over-the-counter CGMs in 39 young adults without diabetes found a mean absolute relative difference of 12.9% against capillary meter readings, worse after a sugary drink (15.3% vs 10.6%), and warned against using them for diagnostic thresholds. The abstract does not name the products.

Can non-diabetics benefit from a CGM?

Not proven. A 2024 meta-analysis of 25 trials was mostly in diabetes and found modest benefits on HbA1c; only 3 trials were in people with obesity, and 44% reported CGM-company conflicts. We found no trial showing health benefit in healthy adults.

Sources

Update log

  1. Rewritten from Stelo's site, an FDA notice and two studies. Removed the unsourced accuracy percentages, $99 price claim and Libre Sense comparison; comparison with Abbott Lingo is on its own page.

Related reading

Wearables

Stelo vs Lingo: CGMs for People Without Diabetes

Dexcom Stelo vs Abbott Lingo from the brands' pages and FDA: price, wear time, who each is for, and what studies say about CGM use without diabetes.

4 min readRead
WearablesFeatured

Best CGMs for Non-Diabetics: Are They Worth It?

Compare the CGM options for people without diabetes, from the brands' own pages, with wear time, price, and what the evidence does and does not show.

3 min readRead
Wearables

Smart Rings Compared: Oura Ring 4 and 5 Cost, Accuracy

Oura Ring 4 and Ring 5 prices and membership cost, how other smart rings compare on subscriptions, and what sleep and HRV validation studies found.

6 min readRead